This content is machine translated Severe asthma Anti-IL-5/-5Rα biologics impress in the real world Three biologics targeting interleukin 5 (IL-5) or its receptor (IL-5Rα) are approved for use in patients with severe asthma. In a meta-analysis, Greek scientists have now investigated the clinical response...…
View Post 4 min This content is machine translated Asthma: focus on type 2 inflammation Remission as a new therapeutic goal A paradigm shift is emerging in the management of asthma, where the aim is not only asthma control but also remission. It has been shown that this ambitious goal can...…
View Post 2 min This content is machine translated Severe asthma and psoriasis Biologics combination leads to success Biologics are now established treatment options, particularly for severe courses of the disease. However, there is little data on the the efficacy and safety of simultaneous administration of several biologics…
View Post 5 min This content is machine translated Severe asthma Check diagnosis and initiate phenotype-based therapy In patients with inadequately controlled asthma under maximum inhalation therapy, it should be critically questioned whether the diagnosis of asthma is really present and whether all treatment measures are being…
View Post 2 min This content is machine translated Eosinophilic asthma Mepolizumab now also available as pen and prefilled syringe At the beginning of August 2019, GSK received approval from the EMA for two new dosage forms of mepolizumab: The IL-5 antibody can now also be administered as a pen…
View Post 4 min This content is machine translated Chronic rhinosinusitis Colorful mixture instead of independent disease? If a patient suffers from chronic inflammation of the mucous membranes in the nose and sinuses, it is important to look closely. Especially the polypous variant could be associated with…
